P3 Health Partners Inc (PIII)
0.215
+0.01
(+5.50%)
USD |
NASDAQ |
Nov 21, 16:00
0.2199
0.00 (0.00%)
After-Hours: 20:00
P3 Health Partners Net Income (Quarterly): -46.51M for Sept. 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -46.51M |
June 30, 2024 | -12.02M |
March 31, 2024 | -18.70M |
December 31, 2023 | -25.46M |
September 30, 2023 | -13.30M |
June 30, 2023 | -9.816M |
March 31, 2023 | -9.199M |
December 31, 2022 | -94.03M |
Date | Value |
---|---|
September 30, 2022 | -11.17M |
June 30, 2022 | -154.35M |
March 31, 2022 | -10.58M |
September 30, 2021 | -32.05M |
June 30, 2021 | -29.46M |
March 31, 2021 | -24.65M |
June 30, 2020 | -4.188M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-154.35M
Minimum
Jun 2022
-4.188M
Maximum
Jun 2020
-33.03M
Average
-18.70M
Median
Mar 2024
Net Income (Quarterly) Benchmarks
American Shared Hospital Services | -0.207M |
Omnicell Inc | 8.63M |
Astrana Health Inc | 16.09M |
Cryo-Cell International Inc | 1.052M |
Biote Corp | 10.70M |
Net Income (Quarterly) Related Metrics
Revenue (Quarterly) | 362.12M |
Total Expenses (Quarterly) | 469.11M |
EPS Diluted (Quarterly) | -0.31 |
Enterprise Value | 248.89M |
Profit Margin (Quarterly) | -12.84% |
Earnings Yield | -400.0% |
Normalized Earnings Yield | -439.80 |